The inhibitory effects of 15-d-PGJ2 were additive with fluticasone, offering the intriguing possibility that PPARγ agonists in combination with corticosteroids may provide additional therapeutic benefit in asthma [53]. This evidence concerns the gene PPARG and asthma.